{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:51:27Z","timestamp":1781650287688,"version":"3.54.5"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Dubai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lyme disease is the most widespread tick-borne infection in the Northern Hemisphere and is challenging to diagnose and treat due to its changing clinical presentation, antigenic variation, tissue tropism, and the expanding distribution of vectors. This review includes ecology, pathogenesis, diagnostics, treatment, post-treatment, prevention, and novel translational approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature review was conducted to include literature published between January 2000 and March 2026 in PubMed\/MEDLINE, Scopus, and Web of Science, with landmark studies used where applicable. Original research, clinical trials, systematic reviews, and major public health reports were prioritised.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two-tier serology is the most common diagnostic technique, but it has limited sensitivity in early infection and does not distinguish between active and past infection. Culture and PCR are only useful in a few instances. The use of new technologies such as multiomics biomarkers, metagenomics, T-cell assays, and AI-enhanced diagnostics is promising but has not yet been tested in a prospective multicentre study. Most of the early and disseminated disease can be treated with standard antibiotics, whereas the long-term therapy of PTLD is not justified and can cause more adverse effects. These preventive and curative advancements involve VLA15 vaccination, anti-tick and reservoir-specific approaches, microbiome-engineered vectors, and anti-persister\/ biofilm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lyme disease requires combined prevention, improved diagnostics, enhanced biomarker research, and well-designed PTLD trials. The short-term benefits will be based on the optimisation of existing diagnostics and vector control, and the long-term benefits will be based on rigorous validation of vaccines, biomarkers, and specific therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12245-026-01182-5","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:36:18Z","timestamp":1775925378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology, diagnosis and emerging therapies for Lyme disease of the Northern Hemisphere"],"prefix":"10.1186","volume":"19","author":[{"given":"Shairy","family":"Priya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik Belagodu","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javedh","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurugan","family":"Balusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanalekshmi Unnikrishnan","family":"Meenakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Sundram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabha","family":"Malviya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"1182_CR1","unstructured":"Centers for Disease Control and Prevention (CDC). Lyme disease surveillance and data [Internet]. Atlanta (GA): CDC; [cited 2025 Dec 11]. Available from: https:\/\/www.cdc.gov\/lyme\/data-research\/facts-stats\/index.html."},{"issue":"2","key":"1182_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3201\/eid2702.202731","volume":"27","author":"KJ Kugeler","year":"2021","unstructured":"Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF. Estimating the frequency of Lyme disease diagnoses, United States, 2010-2018. Emerg Infect Dis. 2021 Feb 27(2):616\u201319. https:\/\/doi.org\/10.3201\/eid2702.202731.","journal-title":"Emerg Infect Dis"},{"key":"1182_CR3","unstructured":"Pfizer Inc. Phase 3 VALOR Lyme disease trial: Valneva and Pfizer announce primary vaccination series completion [Internet]. New York (NY): Pfizer; [cited 2025 Dec 11]. Available from: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/phase-3-valor-lyme-disease-trial-valneva-and-pfizer."},{"key":"1182_CR4","unstructured":"Centers for Disease Control and Prevention (CDC). Technical documentation: Lyme disease [Internet]. Atlanta (GA): CDC; [cited 2025 Dec 11]. Available from: https:\/\/doi.org\/www.cdc.gov\/mmwr\/mmwr_nd\/index.html"},{"key":"1182_CR5","doi-asserted-by":"publisher","unstructured":"Maldonado-Ruiz P. The tick microbiome: the \u2018other bacterial players\u2019 in tick biocontrol. Microorganisms. 2024 Dec 12(12). https:\/\/doi.org\/10.3390\/MICROORGANISMS12122451.","DOI":"10.3390\/MICROORGANISMS12122451"},{"key":"1182_CR6","doi-asserted-by":"publisher","unstructured":"Narasimhan S, et al. Tick transmission of Borrelia burgdorferi to the murine host is not influenced by environmentally acquired midgut microbiota. Microbiome. 2022 Dec;10(1). https:\/\/doi.org\/10.1186\/S40168-022-01378-W.","DOI":"10.1186\/S40168-022-01378-W"},{"key":"1182_CR7","doi-asserted-by":"publisher","unstructured":"Carrera-Faja L, et al. Microbiome-based surveillance of zoonotic tick-borne pathogens from urban wild boars in Barcelona, 2022-2023. One Health. 2025 Jun;20. https:\/\/doi.org\/10.1016\/j.onehlt.2025.101022.","DOI":"10.1016\/j.onehlt.2025.101022"},{"issue":"3","key":"1182_CR8","doi-asserted-by":"publisher","first-page":"100246","DOI":"10.1016\/J.MCPDIG.2025.100246","volume":"3","author":"M Zack","year":"2025","unstructured":"Zack M, et al. Artificial intelligence and multi-omics in pharmacogenomics: a new era of precision medicine. Mayo Clinic Proc Digit Health. 2025 Sep;3(3):100246. https:\/\/doi.org\/10.1016\/J.MCPDIG.2025.100246.","journal-title":"Mayo Clinic Proc: Digit Health"},{"key":"1182_CR9","doi-asserted-by":"publisher","unstructured":"Cabello FC, Embers ME, Newman SA, Godfrey HP. Borreliella burgdorferi antimicrobial-tolerant persistence in Lyme disease and posttreatment Lyme disease syndromes. mBio. 2022 Jun;13(3). https:\/\/doi.org\/10.1128\/MBIO.03440-21.","DOI":"10.1128\/MBIO.03440-21"},{"issue":"6","key":"1182_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/BJD.20977","volume":"186","author":"A Gindl","year":"2022","unstructured":"Gindl A, et al. Persistent Lyme disease with cutaneous Borrelia biofilm formation. Br J Dermatol. 2022 Jun;186(6):1041\u201343. https:\/\/doi.org\/10.1111\/BJD.20977.","journal-title":"Br J Dermatol"},{"key":"1182_CR11","doi-asserted-by":"publisher","unstructured":"Coughlin JM, et al. Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET. J Neuroinflammation. 2018, Dec;15(1). https:\/\/doi.org\/10.1186\/S12974-018-1381-4.","DOI":"10.1186\/S12974-018-1381-4"},{"issue":"11","key":"1182_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","volume":"19","author":"WC Kreisl","year":"2020","unstructured":"Kreisl WC, Kim MJ, Coughlin JM, Henter ID, Owen DR, Innis RB. PET imaging of neuroinflammation in neurological disorders. Lancet Neurol. 2020 Nov;19(11):940. https:\/\/doi.org\/10.1016\/S1474-4422(20)30346-X.","journal-title":"The Lancet Neurol"},{"key":"1182_CR13","unstructured":"\u201cValneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook - Valneva. Accessed: Dec. 11, 2025. [Online]. Available: https:\/\/valneva.com\/press-release\/valneva-reports-preliminary-unaudited-2024-revenue-and-cash-and-provides-2025-outlook\/"},{"issue":"1","key":"1182_CR14","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/J.TTBDIS.2023.102286","volume":"15","author":"RJ Eisen","year":"2024","unstructured":"Eisen RJ, Eisen L. Evaluation of the association between climate warming and the spread and proliferation of Ixodes scapularis in northern states in the Eastern United States. Ticks Tick Borne Dis. 2024 Jan;15(1):102286. https:\/\/doi.org\/10.1016\/J.TTBDIS.2023.102286.","journal-title":"Ticks Tick Borne Dis"},{"key":"1182_CR15","doi-asserted-by":"publisher","unstructured":"Westcott JR, Bowden JJ, Savage J, Doody KM. Rapid northward expansion of the blacklegged tick, Ixodes scapularis, in response to climate change. Glob Chang Biol. 2025 Nov;31(11):e70591. https:\/\/doi.org\/10.1111\/GCB.70591.","DOI":"10.1111\/GCB.70591"},{"issue":"1","key":"1182_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/JME\/TJAB169","volume":"59","author":"H Baldwin","year":"2021","unstructured":"Baldwin H, Landesman WJ, Borgmann-Winter B, Allen D. A geographic Information system approach to map tick exposure risk at a scale for public Health intervention. J Med Entomol. 2021 Jan;59(1):162. https:\/\/doi.org\/10.1093\/JME\/TJAB169.","journal-title":"J Med Entomol"},{"key":"1182_CR17","doi-asserted-by":"publisher","unstructured":"Deshpande G, Beetch JE, Heller JG, Naqvi OH, Kuhn KG. Assessing the influence of climate change and environmental factors on the Top tick-borne Diseases in the United States: a systematic review. Microorganisms. 2024 Jan;12(1). https:\/\/doi.org\/10.3390\/MICROORGANISMS12010050\/S1.","DOI":"10.3390\/MICROORGANISMS12010050\/S1"},{"key":"1182_CR18","doi-asserted-by":"publisher","unstructured":"Garshong RA, et al. Expanding range of Ixodes scapularis say (Acari: ixodidae) and Borrelia burgdorferi infection in North Carolina counties, 2018-2023. PLoS One. 2025 Aug;20(8):e0329511. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0329511.","DOI":"10.1371\/JOURNAL.PONE.0329511"},{"issue":"6","key":"1182_CR19","doi-asserted-by":"publisher","first-page":"102230","DOI":"10.1016\/J.TTBDIS.2023.102230","volume":"14","author":"HK Goethert","year":"2023","unstructured":"Goethert HK, Mather TN, O\u2019Callahan A, Telford Iii SRR. Host-utilization differences between larval and nymphal deer ticks in northeastern U.S. sites enzootic for Borrelia burgdorferi sensu stricto. Ticks Tick Borne Dis. 2023 Nov;14(6):102230. https:\/\/doi.org\/10.1016\/J.TTBDIS.2023.102230.","journal-title":"Ticks Tick Borne Dis"},{"issue":"5","key":"1182_CR20","doi-asserted-by":"publisher","first-page":"102203","DOI":"10.1016\/J.TTBDIS.2023.102203","volume":"14","author":"GA Matulis","year":"2023","unstructured":"Matulis GA, et al. Applying next generation sequencing to detect tick-pathogens in dermacentor nuttalli, Ixodes persulcatus, and hyalomma asiaticum collected from Mongolia. Ticks Tick Borne Dis. 2023 Sep;14(5):102203. https:\/\/doi.org\/10.1016\/J.TTBDIS.2023.102203.","journal-title":"Ticks Tick Borne Dis"},{"key":"1182_CR21","doi-asserted-by":"publisher","unstructured":"Goethert HK, Telford SR. Host contributions to the force of Borrelia burgdorferi and Babesia microti transmission differ at edges of and within a small habitat patch. Appl Environ Microbiol. 2022 Mar;88(6):e02391\u201321. https:\/\/doi.org\/10.1128\/AEM.02391-21.","DOI":"10.1128\/AEM.02391-21"},{"key":"1182_CR22","doi-asserted-by":"publisher","unstructured":"Martins PM, Mahon MB, Rohr JR. Reservoir host community and vector density predict human tick-borne diseases across the Eastern United States. Sci Rep. 2025 Dec;15(1). https:\/\/doi.org\/10.1038\/S41598-025-22637-4.","DOI":"10.1038\/S41598-025-22637-4"},{"key":"1182_CR23","doi-asserted-by":"publisher","unstructured":"Goethert HK, Telford SR. Limited capacity of deer to serve as zooprophylactic hosts for Borrelia burgdorferi in the northeastern United States. Appl Environ Microbiol. 2022, Mar;88(6). https:\/\/doi.org\/10.1128\/AEM.00042-22.","DOI":"10.1128\/AEM.00042-22"},{"key":"1182_CR24","doi-asserted-by":"publisher","unstructured":"Wiesinger A, Wenderlein J, Ulrich S, Hiereth S, Chitimia-Dobler L, Straubinger RK. Revealing the tick microbiome: insights into midgut and salivary gland microbiota of female Ixodes ricinus ticks. Int J Mol Sci. 2023 Jan;24(2). https:\/\/doi.org\/10.3390\/IJMS24021100\/S1.","DOI":"10.3390\/IJMS24021100\/S1"},{"key":"1182_CR25","doi-asserted-by":"publisher","unstructured":"Mulavu M, et al. Defining the bacterial microbiome of ticks in Chongwe and chisamba districts of Zambia. Infect Med (Beijing). 2024 Dec;3(4). https:\/\/doi.org\/10.1016\/j.imj.2024.100131.","DOI":"10.1016\/j.imj.2024.100131"},{"key":"1182_CR26","doi-asserted-by":"publisher","unstructured":"Wu-Chuang A, et al. Microbiota perturbation by anti-microbiota vaccine reduces the colonization of Borrelia afzelii in Ixodes ricinus. Microbiome. 2023 Dec;11(1). https:\/\/doi.org\/10.1186\/s40168-023-01599-7.","DOI":"10.1186\/s40168-023-01599-7"},{"key":"1182_CR27","doi-asserted-by":"publisher","unstructured":"Mateos-Hernandez L, et al. Antimicrobiota vaccine induces lysine-mediated modulation of tick immunity affecting Borrelia colonization. FEMS Microbiol Ecol. 2025 Sep;101(9). https:\/\/doi.org\/10.1093\/femsec\/fiaf082.","DOI":"10.1093\/femsec\/fiaf082"},{"key":"1182_CR28","doi-asserted-by":"publisher","unstructured":"Huang W, Van Den Berg LP, Jacobs-Lorena M. Combining transgenesis with paratransgenesis to fight vector-borne disease: lessons from mosquito systems. eLife. 2022. https:\/\/doi.org\/10.7554\/eLife.77584.","DOI":"10.7554\/eLife.77584"},{"key":"1182_CR29","doi-asserted-by":"publisher","unstructured":"Chumachenko D, et al. Predictive model of Lyme disease epidemic process using machine learning approach. Appl Sci. 2022 Apr. 2022;12(9). https:\/\/doi.org\/10.3390\/APP12094282.","DOI":"10.3390\/APP12094282"},{"key":"1182_CR30","doi-asserted-by":"publisher","first-page":"1469411","DOI":"10.3389\/FMICB.2024.1469411\/TEXT","volume":"15","author":"SJ Norris","year":"2024","unstructured":"Norris SJ, Brangulis K. Meta-analysis of the Vmp-like sequences of Lyme disease Borrelia: evidence for the evolution of an elaborate antigenic variation system. Front Microbiol. 2024 Oct;15:1469411. https:\/\/doi.org\/10.3389\/FMICB.2024.1469411\/TEXT.","journal-title":"Front Microbiol"},{"issue":"3","key":"1182_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/PATHOGENS10030281","volume":"10","author":"C Anderson","year":"2021","unstructured":"Anderson C, Brissette CA. The brilliance of Borrelia: mechanisms of host immune evasion by Lyme disease-causing spirochetes. Pathogens. 2021 Mar;10(3):1\u201317. https:\/\/doi.org\/10.3390\/PATHOGENS10030281.","journal-title":"Pathogens"},{"key":"1182_CR32","doi-asserted-by":"publisher","unstructured":"Greenmyer JR, Gaultney RA, Brissette CA, Watt JA. Primary human microglia are phagocytically active and respond to Borrelia burgdorferi with upregulation of chemokines and cytokines. Front Microbiol. 2018 APR;9. https:\/\/doi.org\/10.3389\/FMICB.2018.00811.","DOI":"10.3389\/FMICB.2018.00811"},{"issue":"16","key":"1182_CR33","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/1873-3468.13894","volume":"594","author":"V Dulipati","year":"2020","unstructured":"Dulipati V, Meri S, Panelius J. Complement evasion strategies of Borrelia burgdorferi sensu lato. FEBS Lett. 2020 Aug;594(16):2645\u201356. https:\/\/doi.org\/10.1002\/1873-3468.13894.","journal-title":"FEBS Lett"},{"key":"1182_CR34","doi-asserted-by":"publisher","unstructured":"Strnad M, Rudenko N, Rego ROM. Pathogenicity and virulence of Borrelia burgdorferi. Virulence. 2023;14(1). https:\/\/doi.org\/10.1080\/21505594.2023.2265015.","DOI":"10.1080\/21505594.2023.2265015"},{"key":"1182_CR35","doi-asserted-by":"publisher","first-page":"1619660","DOI":"10.3389\/FCIMB.2025.1619660\/BIBTEX","volume":"15","author":"G Fabrizio","year":"2025","unstructured":"Fabrizio G, et al. Genomic characterization and antibiotic susceptibility of biofilm-forming Borrelia afzelii and Borrelia garinii from patients with erythema migrans. Front Cell Infect Microbiol. 2025 Jul;15:1619660. https:\/\/doi.org\/10.3389\/FCIMB.2025.1619660\/BIBTEX.","journal-title":"Front Cell Infect Microbiol"},{"issue":"148","key":"1182_CR36","first-page":"125","volume":"27","author":"J Feng","year":"2019","unstructured":"Feng J, Li T, Yee R, Yuan Y, Bai C, Cai M, et al. Stationary phase persister\/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, post-treatment Lyme disease syndrome (PTLDS), and treatment failure. Discov Med. 2019 Mar;27(148):125\u201338. PMID: 30946803.","journal-title":"Discov Med"},{"issue":"8","key":"1182_CR37","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1128\/AAC.00864-15","volume":"59","author":"B Sharma","year":"2015","unstructured":"Sharma B, Brown AV, Matluck NE, Hu LT, Lewis K. Borrelia burgdorferi, the causative Agent of Lyme disease, forms drug-tolerant persister cells. Antimicrob Agents Chemother. 2015 Aug;59(8):4616\u201324. https:\/\/doi.org\/10.1128\/AAC.00864-15.","journal-title":"Antimicrob Agents Chemother"},{"key":"1182_CR38","doi-asserted-by":"publisher","unstructured":"Feng J, Weitner M, Shi W, Zhang S, Zhang Y. Eradication of biofilm-like microcolony structures of Borrelia burgdorferi by Daunomycin and daptomycin but not mitomycin C in combination with doxycycline and cefuroxime. In: Front. Microbiol. Vol. 7. FEB; 2016 Feb. https:\/\/doi.org\/10.3389\/FMICB.2016.00062.","DOI":"10.3389\/FMICB.2016.00062"},{"issue":"5","key":"1182_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.chom.2009.10.006","volume":"6","author":"J Dai","year":"2009","unstructured":"Dai J, et al. Antibodies against a tick protein, Salp15, protect mice from the Lyme disease Agent. Cell Host Microbe. 2009 Nov;6(5):482\u201392. https:\/\/doi.org\/10.1016\/j.chom.2009.10.006.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"1182_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/S00005-014-0324-8","volume":"63","author":"G Neelakanta","year":"2014","unstructured":"Neelakanta G, Sultana H. Transmission-blocking vaccines: focus on anti-vector vaccines against tick-borne diseases. Arch. Immunol Ther Exp (Warsz). 2014 Jun;63(3):169. https:\/\/doi.org\/10.1007\/S00005-014-0324-8.","journal-title":"Arch. Immunol Ther Exp (Warsz)"},{"issue":"8","key":"1182_CR41","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/BRAIN\/AWAC206","volume":"145","author":"JJ Halperin","year":"2022","unstructured":"Halperin JJ, Eikeland R, Branda JA, Dersch R. Lyme neuroborreliosis: known knowns, known unknowns. Brain. 2022 Aug;145(8):2635\u201347. https:\/\/doi.org\/10.1093\/BRAIN\/AWAC206.","journal-title":"Brain"},{"key":"1182_CR42","unstructured":"Skar GL, Blum MA, Simonsen KA. Lyme disease. StatPearls, Oct. 2024, Accessed: Dec. 2025. [Online]. Available: 16. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK431066\/."},{"issue":"2","key":"1182_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/S10096-018-3417-1","volume":"38","author":"JA Cardenas-de la Garza","year":"2019","unstructured":"Cardenas-de la Garza JA, De la Cruz-Valadez E, Ocampo-Candiani J, Welsh O. Clinical spectrum of Lyme disease. Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):201\u201308. https:\/\/doi.org\/10.1007\/S10096-018-3417-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"1182_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.idc.2022.02.006","volume":"36","author":"T Crissinger","year":"2022","unstructured":"Crissinger T, Baldwin K. Early disseminated Lyme disease: cranial neuropathy, meningitis, and Polyradiculopathy. Infect Dis Clin N Am. 2022 Sep;36(3):541\u201351. https:\/\/doi.org\/10.1016\/j.idc.2022.02.006.","journal-title":"Infect Dis Clin N Am"},{"key":"1182_CR45","doi-asserted-by":"publisher","unstructured":"Grella BA, Patel M, Tadepalli S, Bader CW, Kronhaus K. Lyme carditis: a Rare presentation of sinus bradycardia without any conduction defects. Cureus. 2019 Sep;11(9):e5554. https:\/\/doi.org\/10.7759\/cureus.5554.","DOI":"10.7759\/cureus.5554"},{"issue":"1","key":"1182_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7326\/0003-4819-93-1-8","volume":"93","author":"AC Steere","year":"1980","unstructured":"Steere AC, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med. 1980;93(1):8\u201316. https:\/\/doi.org\/10.7326\/0003-4819-93-1-8.","journal-title":"Ann Intern Med"},{"key":"1182_CR47","doi-asserted-by":"publisher","unstructured":"Novak P, Felsenstein D, Mao C, Octavien NR, Zubcevik N. Association of small fiber neuropathy and post treatment Lyme disease syndrome. PLoS One. 2019, Feb;14(2). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0212222.","DOI":"10.1371\/JOURNAL.PONE.0212222"},{"key":"1182_CR48","doi-asserted-by":"publisher","unstructured":"Institute of Medicine (US) Committee on Lyme Disease and Other Tick-Borne Diseases: The Scientific Basis of Prevention, Amelioration, and Resolution. Critical needs and gaps in understanding prevention, amelioration, and resolution of Lyme and other tick-borne diseases. Washington (DC): National Academies Press; 2011 May. https:\/\/doi.org\/10.17226\/13134.","DOI":"10.17226\/13134"},{"key":"1182_CR49","doi-asserted-by":"publisher","unstructured":"Gu\u00e9rin M, et al. Lyme borreliosis diagnosis: state of the art of improvements, limitations and perspectives. BMC Microbiol. 2023. https:\/\/doi.org\/10.1186\/s12866-023-02935-5.","DOI":"10.1186\/s12866-023-02935-5"},{"key":"1182_CR50","doi-asserted-by":"publisher","unstructured":"Lantos PM, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021 Jan;72(1):e1\u201348. https:\/\/doi.org\/10.1093\/CID\/CIAA1215.","DOI":"10.1093\/CID\/CIAA1215"},{"issue":"5","key":"1182_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14745\/CCDR.V46I05A05","volume":"46","author":"T Hatchette","year":"2020","unstructured":"Hatchette T, Lindsay R. Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context. Can Commun Dis Rep. 2020 May;46(5):125\u201331. https:\/\/doi.org\/10.14745\/CCDR.V46I05A05.","journal-title":"Can Commun Dis Rep"},{"issue":"1","key":"1182_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/INFDIS\/156.1.183","volume":"156","author":"LA Magnarelli","year":"1987","unstructured":"Magnarelli LA, Anderson JF, Johnson RC. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis. 1987;156(1):183\u201388. https:\/\/doi.org\/10.1093\/INFDIS\/156.1.183.","journal-title":"The J Infect Dis"},{"issue":"2","key":"1182_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","volume":"29","author":"SL Arvikar","year":"2015","unstructured":"Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin N Am. 2015 Jun;29(2):269\u201380. https:\/\/doi.org\/10.1016\/j.idc.2015.02.004.","journal-title":"Infect Dis Clin N Am"},{"key":"1182_CR54","doi-asserted-by":"publisher","unstructured":"Theel ES, Aguero-Rosenfeld ME, Pritt B, Adem PV, Wormser GP. Limitations and confusing aspects of diagnostic testing for Neurologic Lyme disease in the United States. J Clin Microbiol. 2019 Jan;57(1):e01406\u201318. https:\/\/doi.org\/10.1128\/JCM.01406-18.","DOI":"10.1128\/JCM.01406-18"},{"issue":"9","key":"1182_CR55","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/cid\/civ652","volume":"61","author":"PM Lantos","year":"2015","unstructured":"Lantos PM, Branda J, Wormser JP, et al. Poor positive predictive value of Lyme disease serologic screening in a low-prevalence population. Clin Infect Dis. 2015 Nov;61(9):1350\u201356. https:\/\/doi.org\/10.1093\/cid\/civ652.","journal-title":"Clin Infect Dis"},{"key":"1182_CR56","unstructured":"\u201cClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC.\u201d|\u201cClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC.\u201d|\u201cClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC. Accessed: Dec. 16, 2025. [Online]. Available: https:\/\/www.cdc.gov\/lyme\/hcp\/diagnosis-testing\/."},{"key":"1182_CR57","doi-asserted-by":"publisher","unstructured":"Wang T, et al. Evaluation of the epitogen Lyme detect IgG ELISA: a novel peptide multiplexing approach. Microbiol. Spectr. 2024 Dec;12(12). https:\/\/doi.org\/10.1128\/SPECTRUM.01675-24.","DOI":"10.1128\/SPECTRUM.01675-24"},{"key":"1182_CR58","doi-asserted-by":"publisher","unstructured":"Bockenstedt LK, Belperron AA. Insights from omics in Lyme disease. J Infect Dis. 2024 Aug;230(Suppl 1):S18. https:\/\/doi.org\/10.1093\/INFDIS\/JIAE250.","DOI":"10.1093\/INFDIS\/JIAE250"},{"key":"1182_CR59","doi-asserted-by":"publisher","unstructured":"Kehoe ER, et al. Biomarker selection and a prospective metabolite-based machine learning diagnostic for lyme disease. Sci Rep. 2022 Dec;12(1). https:\/\/doi.org\/10.1038\/S41598-022-05451-0.","DOI":"10.1038\/S41598-022-05451-0"},{"issue":"1","key":"1182_CR60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/S10238-025-01803-Y","volume":"25","author":"QW Lan","year":"2025","unstructured":"Lan QW, et al. Identification of potential biomarkers for Lyme disease using bioinformatics and machine learning. Clin Exp Med. 2025 Dec;25(1):341. https:\/\/doi.org\/10.1007\/S10238-025-01803-Y.","journal-title":"Clin Exp Med"},{"issue":"20","key":"1182_CR61","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.3390\/DIAGNOSTICS15202602","volume":"15","author":"C Dong","year":"2025","unstructured":"Dong C, Liu Y, Nie J, Zhang X, Yu F, Zhou Y. Artificial intelligence in Infectious disease diagnostic technologies. Diagnostics. 2025 Oct;15(20):2602. https:\/\/doi.org\/10.3390\/DIAGNOSTICS15202602.","journal-title":"Diagnostics"},{"key":"1182_CR62","doi-asserted-by":"publisher","unstructured":"Xie Y, et al. Establishment of an I-ELISA method based on multi-epitope fusion protein for diagnosis of human brucellosis. PLoS Negl Trop Dis. 2025;19(4):e0012995. https:\/\/doi.org\/10.1371\/JOURNAL.PNTD.0012995.","DOI":"10.1371\/JOURNAL.PNTD.0012995"},{"key":"1182_CR63","doi-asserted-by":"publisher","first-page":"708008","DOI":"10.3389\/FVETS.2021.708008\/BIBTEX","volume":"8","author":"D Yin","year":"2021","unstructured":"Yin D, et al. A multi-epitope fusion protein-based p-ELISA method for diagnosing bovine and goat brucellosis. Front Vet Sci. 2021 Sep;8:708008. https:\/\/doi.org\/10.3389\/FVETS.2021.708008\/BIBTEX.","journal-title":"Front Vet Sci"},{"key":"1182_CR64","doi-asserted-by":"publisher","unstructured":"Haslund-Gourley BS, Wigdahl B, Comunale MA, Haslund-Gourley BS, Wigdahl B, Comunale MA. IgG N-glycan signatures as potential diagnostic and prognostic biomarkers. Diagnostics. 2023 Mar. 2023;13, vol. 13(6). https:\/\/doi.org\/10.3390\/DIAGNOSTICS13061016.","DOI":"10.3390\/DIAGNOSTICS13061016"},{"key":"1182_CR65","doi-asserted-by":"publisher","first-page":"104979","DOI":"10.1016\/j.ebiom.2024.104979","volume":"100","author":"BS Haslund-Gourley","year":"2024","unstructured":"Haslund-Gourley BS, et al. Host glycosylation of immunoglobulins impairs the immune response to acute Lyme disease. EBioMedicine. 2024 Feb;100:104979. https:\/\/doi.org\/10.1016\/j.ebiom.2024.104979.","journal-title":"EBioMedicine"},{"issue":"9","key":"1182_CR66","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, et al. The clinical assessment, treatment, and Prevention of Lyme disease, human granulocytic anaplasmosis, and Babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Nov;43(9):1089\u2013134. https:\/\/doi.org\/10.1086\/508667.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"1182_CR67","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1056\/NEJMCP1314325","volume":"370","author":"ED Shapiro","year":"2014","unstructured":"Shapiro ED. Clinical practice. Lyme disease. N Engl J Med. 2014 May;370(18):1724\u201331. https:\/\/doi.org\/10.1056\/NEJMCP1314325.","journal-title":"N Engl J Med"},{"issue":"4","key":"1182_CR68","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/S11908-011-0184-X","volume":"13","author":"JJ Halperin","year":"2011","unstructured":"Halperin JJ. Neurologic manifestations of lyme disease. Curr Infect Dis Rep. 2011 Aug;13(4):360\u201366. https:\/\/doi.org\/10.1007\/S11908-011-0184-X.","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"1182_CR69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202;PAGEGROUP:STRING:PUBLICATION","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. NEJM Evid. 2001 Jul;345(2):85\u201392. https:\/\/doi.org\/10.1056\/NEJM200107123450202;PAGEGROUP:STRING:PUBLICATION.","journal-title":"NEJM Evid"},{"issue":"13","key":"1182_CR70","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2D","volume":"70","author":"BA Fallon","year":"2008","unstructured":"Fallon BA, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992\u20131003. https:\/\/doi.org\/10.1212\/01.WNL.0000284604.61160.2D.","journal-title":"Neurology"},{"issue":"13","key":"1182_CR71","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMOA1505425","volume":"374","author":"A Berende","year":"2016","unstructured":"Berende A, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. NEJM Evid. 2016 Mar;374(13):1209\u201320. https:\/\/doi.org\/10.1056\/NEJMOA1505425","journal-title":"NEJM Evid"},{"key":"1182_CR72","doi-asserted-by":"publisher","unstructured":"Turk SP, et al. Post-treatment Lyme disease symptoms score: developing a new tool for research. PLoS One. 2019 Nov;14(11). https:\/\/doi.org\/10.1371\/journal.pone.0225012.","DOI":"10.1371\/journal.pone.0225012"},{"issue":"3","key":"1182_CR73","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.idc.2022.04.004","volume":"36","author":"A Marques","year":"2022","unstructured":"Marques A. Persistent symptoms after treatment of Lyme disease. Infect Dis Clin N Am. 2022 Sep;36(3):621\u201338. https:\/\/doi.org\/10.1016\/j.idc.2022.04.004.","journal-title":"Infect Dis Clin N Am"},{"key":"1182_CR74","doi-asserted-by":"publisher","unstructured":"Rebman AW, Aucott JN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front Med (Lausanne). 2020 Feb;7. https:\/\/doi.org\/10.3389\/fmed.2020.00057.","DOI":"10.3389\/fmed.2020.00057"},{"issue":"1","key":"1182_CR75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","volume":"22","author":"JN Aucott","year":"2013","unstructured":"Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res. 2013 Feb;22(1):75\u201384. https:\/\/doi.org\/10.1007\/s11136-012-0126-6.","journal-title":"Qual Life Res"},{"key":"1182_CR76","doi-asserted-by":"publisher","unstructured":"Ursinus J, et al. Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study. Lancet Reg Health - Eur. 2021 Jul;6. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100142.","DOI":"10.1016\/j.lanepe.2021.100142"},{"key":"1182_CR77","doi-asserted-by":"publisher","unstructured":"Embers ME, et al. Persistence of Borrelia burgdorferi in Rhesus macaques following antibiotic treatment of disseminated infection. PLoS One. 2012 Jan;7(1):e29914. https:\/\/doi.org\/10.1371\/journal.pone.0029914.","DOI":"10.1371\/journal.pone.0029914"},{"issue":"12","key":"1182_CR78","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","volume":"60","author":"LB Krupp","year":"2003","unstructured":"Krupp LB, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003 Jun;60(12):1923\u201330. https:\/\/doi.org\/10.1212\/01.WNL.0000071227.23769.9E.","journal-title":"Neurology"},{"key":"1182_CR79","doi-asserted-by":"publisher","unstructured":"Xi D, et al. A longitudinal study of a large clinical cohort of patients with Lyme disease and tick-borne co-infections treated with combination antibiotics. Microorganisms. 2023 Sep;11(9). https:\/\/doi.org\/10.3390\/microorganisms11092152.","DOI":"10.3390\/microorganisms11092152"},{"key":"1182_CR80","doi-asserted-by":"publisher","unstructured":"Clarke DJB, Rebman AW, Fan J, Soloski MJ, Aucott JN, Ma\u2019ayan A. Gene set predictor for post-treatment Lyme disease. Cell Rep. Med. 2022 Nov;3(11). https:\/\/doi.org\/10.1016\/j.xcrm.2022.100816.","DOI":"10.1016\/j.xcrm.2022.100816"},{"key":"1182_CR81","doi-asserted-by":"publisher","unstructured":"Dersch R, Torbahn G, Rauer S. Treatment of post-treatment Lyme disease symptoms-a systematic review. Eur J Neurol. 2024 Jul;31(7). https:\/\/doi.org\/10.1111\/ene.16293.","DOI":"10.1111\/ene.16293"},{"key":"1182_CR82","doi-asserted-by":"publisher","unstructured":"Marvel CL, et al. A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease. PLoS One. 2022 Oct;17(10):e0271425. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0271425.","DOI":"10.1371\/JOURNAL.PONE.0271425"},{"issue":"1","key":"1182_CR83","doi-asserted-by":"publisher","first-page":"20190","DOI":"10.1038\/S41598-025-06146-Y","volume":"15","author":"S Haglund","year":"2025","unstructured":"Haglund S, Gyllemark P, Forsberg P, Brudin L, Tjernberg I, Henningsson AJ. Cerebrospinal fluid protein profiling of inflammatory and neurobiological markers in Lyme neuroborreliosis. Sci Rep. 2025 Dec;15(1):20190. https:\/\/doi.org\/10.1038\/S41598-025-06146-Y.","journal-title":"Sci Rep"},{"issue":"4","key":"1182_CR84","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ARCLIN\/ACY051","volume":"34","author":"P Touradji","year":"2019","unstructured":"Touradji P, Aucott JN, Yang T, Rebman AW, Bechtold KT. Cognitive decline in post-treatment Lyme disease syndrome. Archives Clin Neuropsychol. 2019 Jun;34(4):455\u201365. https:\/\/doi.org\/10.1093\/ARCLIN\/ACY051.","journal-title":"Archives Clin Neuropsychol"},{"key":"1182_CR85","unstructured":"ClinicalTrials.gov. Study details: NCT06915324 \u2014 Transcranial direct current stimulation for post-treatment Lyme disease [Internet]. [cited 2025 Dec 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06915324?utm_source=chatgpt.com."},{"key":"1182_CR86","doi-asserted-by":"publisher","unstructured":"B\u00e9zay N, et al. Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies. Lancet Infect Dis. 2024. https:\/\/doi.org\/10.1016\/S1473-3099(24)00175-0.","DOI":"10.1016\/S1473-3099(24)00175-0"},{"issue":"11","key":"1182_CR87","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S1473-3099(24)00372-4","volume":"24","author":"SK Ghadge","year":"2024","unstructured":"Ghadge SK, Schneider M, Dubischar K, Wagner L, Kadlecek V, Obersriebnig M, et al. Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial. Lancet Infect Dis. 2024 Nov;24(11):1275\u201386. https:\/\/doi.org\/10.1016\/S1473-3099(24)00372-4.","journal-title":"The Lancet Infect Dis"},{"issue":"5","key":"1182_CR88","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1128\/CVI.00758-12","volume":"16","author":"CA Brissette","year":"2009","unstructured":"Brissette CA. Borrelia burgdorferi RevA antigen binds host fibronectin. Clin Vaccine Immunol. 2009;16(5):707\u201311. https:\/\/doi.org\/10.1128\/CVI.00758-12.","journal-title":"Clin Vaccine Immunol"},{"issue":"1\u20132","key":"1182_CR89","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ttbdis.2012.08.006","volume":"4","author":"AJ Ullmann","year":"2013","unstructured":"Ullmann AJ, Dolan MC, Sackal CA, Fikrig E, Piesman J, Zeidner NS. Immunization with adenoviral-vectored tick salivary gland proteins (SALPs) in a murine model of Lyme borreliosis. Ticks Tick Borne Dis. 2013 Feb;4(1\u20132):160\u201363. https:\/\/doi.org\/10.1016\/j.ttbdis.2012.08.006.","journal-title":"Ticks Tick Borne Dis"},{"issue":"12","key":"1182_CR90","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.vaccine.2023.02.003","volume":"41","author":"MJ Klouwens","year":"2023","unstructured":"Klouwens MJ, et al. The Ixodes ricinus salivary gland proteome during feeding and B. afzelii infection: new avenues for an anti-tick vaccine. Vaccine. 2023 Mar;41(12):1951\u201360. https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.003.","journal-title":"Vaccine"},{"key":"1182_CR91","doi-asserted-by":"publisher","unstructured":"Feng J, et al. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg Microbes Infect. 2014 Jul;3(7). https:\/\/doi.org\/10.1038\/EMI.2014.53.","DOI":"10.1038\/EMI.2014.53"},{"key":"1182_CR92","doi-asserted-by":"publisher","first-page":"427933","DOI":"10.3389\/FNEUR.2018.01048\/FULL","volume":"9","author":"EG Di Domenico","year":"2018","unstructured":"Di Domenico EG, et al. The emerging role of microbial biofilm in lyme neuroborreliosis. Front Neurol. 2018 Dec;9:427933. https:\/\/doi.org\/10.3389\/FNEUR.2018.01048\/FULL.","journal-title":"Front Neurol"},{"issue":"10","key":"1182_CR93","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1073\/PNAS.87.10.3768","volume":"87","author":"UE Schaible","year":"1990","unstructured":"Schaible UE, Kramer MD, Eichmann K, Modolell M, Museteanu C, Simon MM. Monoclonal antibodies specific for the outer surface protein a (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc Natl Acad Sci U S A. 1990;87(10):3768\u201372. https:\/\/doi.org\/10.1073\/PNAS.87.10.3768.","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"10","key":"1182_CR94","doi-asserted-by":"publisher","first-page":"5470","DOI":"10.1128\/IAI.67.10.5470-5472.1999","volume":"67","author":"ML Mbow","year":"1999","unstructured":"Mbow ML, Gilmore RD, Titus RG. An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31. Infect Immun. 1999;67(10):5470\u201372. https:\/\/doi.org\/10.1128\/IAI.67.10.5470-5472.1999.","journal-title":"Infect Immun"},{"issue":"2","key":"1182_CR95","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/INFDIS\/JIW151","volume":"214","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. Pre-exposure prophylaxis with OspA-Specific human monoclonal antibodies protects mice against tick transmission of Lyme disease spirochetes. J Infect Dis. 2016 Jul;214(2):205\u201311. https:\/\/doi.org\/10.1093\/INFDIS\/JIW151.","journal-title":"The J Infect Dis"},{"key":"1182_CR96","doi-asserted-by":"publisher","unstructured":"Schiller ZA, et al. Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody. J Clin Invest. 2021 Jun;131(11). https:\/\/doi.org\/10.1172\/JCI144843.","DOI":"10.1172\/JCI144843"},{"issue":"52","key":"1182_CR97","doi-asserted-by":"publisher","first-page":"18159","DOI":"10.1073\/PNAS.0405763102","volume":"101","author":"JI Tsao","year":"2004","unstructured":"Tsao JI, Wootton JT, Bunikis J, Luna MG, Fish D, Barbour AG. An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc Natl Acad Sci. U. S. A. 2004 Dec;101(52):18159\u201364. https:\/\/doi.org\/10.1073\/PNAS.0405763102.","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"12","key":"1182_CR98","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/INFDIS\/JIU005","volume":"209","author":"LM Richer","year":"2014","unstructured":"Richer LM, Brisson D, Melo R, Ostfeld RS, Zeidner N, Gomes-Solecki M. Reservoir targeted vaccine against Borrelia burgdorferi: a new strategy to prevent Lyme disease transmission. J Infect Dis. 2014 Jun;209(12):1972\u201380. https:\/\/doi.org\/10.1093\/INFDIS\/JIU005.","journal-title":"The J Infect Dis"},{"key":"1182_CR99","doi-asserted-by":"publisher","unstructured":"Schulze TL, Eisen L, Russell K, Jordan RA. Community-based integrated tick management programs: cost and feasibility scenarios. J Med Entomol. 2023 1048, Sep;60(5). https:\/\/doi.org\/10.1093\/JME\/TJAD093.","DOI":"10.1093\/JME\/TJAD093"},{"issue":"2","key":"1182_CR100","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/infdis\/jiv775","volume":"214","author":"AF Hinckley","year":"2016","unstructured":"Hinckley AF, et al. Effectiveness of residential Acaricides to prevent Lyme and other tick-borne diseases in humans. J Infect Dis. 2016 Jul;214(2):182\u201388. https:\/\/doi.org\/10.1093\/infdis\/jiv775.","journal-title":"The J Infect Dis"},{"issue":"6","key":"1182_CR101","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1093\/jme\/tjab131","volume":"58","author":"JT Mandli","year":"2021","unstructured":"Mandli JT, Lee X, Bron GM, Paskewitz SM. Integrated tick management in south central Wisconsin: impact of invasive vegetation removal and host-targeted acaricides on the density of questing Ixodes scapularis (Acari: ixodidae) nymphs. J Med Entomol. 2021 Nov;58(6):2358\u201367. https:\/\/doi.org\/10.1093\/jme\/tjab131.","journal-title":"J Med Entomol"},{"issue":"5","key":"1182_CR102","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/zph.12245","volume":"63","author":"KJ Kugeler","year":"2016","unstructured":"Kugeler KJ, Jordan RA, Schulze TL, Griffith KS, Mead PS. Will culling white-tailed deer prevent Lyme disease? Zoonoses Public Health. 2016 Aug;63(5):337\u201345. https:\/\/doi.org\/10.1111\/zph.12245.","journal-title":"Zoonoses Public Health"},{"key":"1182_CR103","doi-asserted-by":"publisher","first-page":"1549348","DOI":"10.3389\/FINSC.2025.1549348","volume":"5","author":"HS Tiffin","year":"2025","unstructured":"Tiffin HS, Gordon JR, Poh KC. One Health, many approaches: integrated vector management strategies support One Health goals. Front Insect Sci. 2025;5:1549348. https:\/\/doi.org\/10.3389\/FINSC.2025.1549348.","journal-title":"Front Insect Sci"},{"issue":"44","key":"1182_CR104","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1016\/J.VACCINE.2011.07.100","volume":"29","author":"D Bhattacharya","year":"2011","unstructured":"Bhattacharya D, et al. Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease. Vaccine. 2011 Oct;29(44):7818\u201325. https:\/\/doi.org\/10.1016\/J.VACCINE.2011.07.100.","journal-title":"Vaccine"},{"key":"1182_CR105","unstructured":"VDCI. VDCI\u2019s guide to enjoying the outdoors: Tick edition [Internet]. [cited 2025 Dec 20]. Available https:\/\/www.vdci.net\/blog\/tick-management\/."},{"issue":"1","key":"1182_CR106","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/JIPM\/PMX018","volume":"8","author":"KC Stafford","year":"2017","unstructured":"Stafford KC, Williams SC, Molaei G. Integrated Pest management in controlling ticks and tick-associated Diseases. J Integr Pest Manag. 2017 Jan;8(1):28. https:\/\/doi.org\/10.1093\/JIPM\/PMX018.","journal-title":"J Integr Pest Manag"},{"issue":"9","key":"1182_CR107","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3201\/eid2109.150417","volume":"21","author":"CA Nelson","year":"2015","unstructured":"Nelson CA, Saha AS, Kugeler M, Mead PR. Incidence of clinician-diagnosed Lyme disease, United States, 2005-2010. Emerg Infect Dis. 2015 Sep;21(9):1625\u201331. https:\/\/doi.org\/10.3201\/eid2109.150417.","journal-title":"Emerg Infect Dis"},{"key":"1182_CR108","doi-asserted-by":"publisher","unstructured":"Kester K, Liao J, March A. Charting a path toward new treatments for Lyme infection-associated chronic illnesses. Washington (DC): National Academies Press; 2025 Jul. p. 1\u2013225. https:\/\/doi.org\/10.17226\/28578.","DOI":"10.17226\/28578"},{"key":"1182_CR109","doi-asserted-by":"publisher","unstructured":"Johnson L, Shapiro M, Needell D, Stricker RB. Optimizing exclusion criteria for clinical trials of persistent Lyme disease using real-world data. Healthcare (Basel). 2024 Jan;13(1). https:\/\/doi.org\/10.3390\/HEALTHCARE13010020.","DOI":"10.3390\/HEALTHCARE13010020"},{"key":"1182_CR110","doi-asserted-by":"publisher","unstructured":"Ben-Eltriki M, et al. Adaptive designs in clinical trials: a systematic review-part I. BMC Med Res Methodol. 2024 Dec;24(1). https:\/\/doi.org\/10.1186\/S12874-024-02272-9.","DOI":"10.1186\/S12874-024-02272-9"},{"key":"1182_CR111","doi-asserted-by":"publisher","unstructured":"Fitzgerald BL, et al. Metabolic response in patients with post-treatment Lyme disease symptoms\/syndrome. Clin Infect Dis. 2021 Oct;73(7):e2342\u201349. https:\/\/doi.org\/10.1093\/CID\/CIAA1455.","DOI":"10.1093\/CID\/CIAA1455"},{"issue":"4","key":"1182_CR112","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/SIM.4780080407","volume":"8","author":"RL Prentice","year":"1989","unstructured":"Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med. 1989;8(4):431\u201340. https:\/\/doi.org\/10.1002\/SIM.4780080407.","journal-title":"Stat Med"},{"key":"1182_CR113","doi-asserted-by":"publisher","unstructured":"Kaizer AM, et al. Recent innovations in adaptive trial designs: a review of design opportunities in translational research. J Clin Transl Sci. 2023 Apr;7(1). https:\/\/doi.org\/10.1017\/CTS.2023.537.","DOI":"10.1017\/CTS.2023.537"},{"issue":"8","key":"1182_CR114","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/J.PT.2021.04.004","volume":"37","author":"S Narasimhan","year":"2021","unstructured":"Narasimhan S, Swei A, Abouneameh S, Pal U, Pedra JHF, Fikrig E. Grappling with the tick microbiome. Trends Parasitol. 2021 Aug;37(8):722. https:\/\/doi.org\/10.1016\/J.PT.2021.04.004.","journal-title":"Trends Parasitol"},{"key":"1182_CR115","doi-asserted-by":"publisher","unstructured":"Destoumieux-Garz\u00f3n D, et al. The One Health concept: 10 years old and a long road ahead. Front Vet Sci. 2018 Feb 14;5, art. https:\/\/doi.org\/10.3389\/fvets.2018.00014.","DOI":"10.3389\/fvets.2018.00014"},{"issue":"2","key":"1182_CR116","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/JCM13020403","volume":"13","author":"Z Biskupiak","year":"2024","unstructured":"Biskupiak Z, Ha VV, Rohaj A, Bulaj G. Digital therapeutics for improving effectiveness of pharmaceutical drugs and biological products: preclinical and clinical studies supporting development of drug + digital combination therapies for chronic diseases. J Clin Med. 2024 Jan;13(2):403. https:\/\/doi.org\/10.3390\/JCM13020403.","journal-title":"J Clin Med"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-026-01182-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-026-01182-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-026-01182-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:51:42Z","timestamp":1781646702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12245-026-01182-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1182"],"URL":"https:\/\/doi.org\/10.1186\/s12245-026-01182-5","relation":{},"ISSN":["1865-1380"],"issn-type":[{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}